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A locus for van Recklinghausen neurofibromatosis 
(NFl) has recently been mapped near the chromo- 
some 17 centromere. We have extended these linkage 
studies by genotyping 45 NFl families with three 
DNA probes known to be linked to the chromosome 17 
centromeric region. Of 34 families informative for 
NFl and at least one of the three probes, 28 families 
show no recombinants with the disease gene. These 
data provide additional support for genetic homoge- 
neity of NFl and for a primary NFl locus linked to 
the chromosome 17 centromere. Among the informa- 
tive families were 7 families with apparent new NFl 
mutations. Our data suggest that these mutations are 
probably at the chromosome 17 NFl locus. 0 1987 
Academic Prese, Inc. 
INTRODUCTION 
von Recklinghausen neurofibromatosis (NFl) is an 
autosomal dominant disorder with an incidence of 1 
in 3000 individuals and a high mutation rate esti- 
mated at 0.0001 mutation per gamete per generation 
(Crowe et al., 1956). The diagnostic features are multi- 
ple superficial neurofibromas, hyperpigmented skin 
macules, and iris Lisch nodules, although additional 
clinical manifestations are often observed (for a re- 
cent review see Riccardi and Eichner, 1986). Expres- 
sion of the disease is variable; both the types of lesions 
and their severity differ widely even among individ- 
uals of a single family (Riccardi, 1981). A locus for 
NFl has recently been identified by genetic linkage to 
DNA probes on chromosome 17 in 23 pedigrees 
(Barker et al., 1987a; Seizinger et aZ., 1987). These 
data show that a locus for NFl is on chromosome 17 
in these families; however, linkage analysis on addi- 
1 To whom correspondence should be addressed. 
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tional families is necessary to determine if there is 
more than one NFl locus. 
Since the existence of genetic heterogeneity would 
have important implications for future diagnostic 
testing with DNA probes, and isolation and character- 
ization of the NFl gene(s), we have begun genotyping 
a large collection of NFl families with chromosome 17 
probes. In this paper we report the results of genotyp- 
ing 45 NFl-affected families with three chromosome 
17 DNA markers. Our data provide additional support 
for the genetic homogeneity of NFl. 
MATERIALS AND METHODS 
Family Resouces 
The 45 NFl-affected families used in this study 
were contributed by two centers: 40 families from the 
Baylor Neurofibromatosis Program (designated 
BAY) were diagnosed and collected by V.M.R., and 5 
families from the University of Michigan (designated 
UMI) were diagnosed and collected by F.S.C. The 5 
UMI families were also used in the study by Diehl et 
ul. (this volume). These 45 families comprise 282 indi- 
viduals, with the children representing 165 meioses, 
and represent a variety of ethnic backgrounds. The 
criteria for diagnosis of NFl are outlined in Riccardi 
and Eichner (1986) and Riccardi and Cary (1987). 
Blood drawn from affected and at-risk individuals in 
these two sets of families was sent to Collaborative 
Research, Inc., where lymphoblastoid cell lines were 
established by transformation with Epstein-Barr 
virus. 
The genotypes for the three DNA markers on the 
NFl families were combined with the genotypes pre- 
viously compiled (see below) on 21 multigenerational 
nondisease families provided by the Centre d’Etude 
du Polymorphisme Humain (CEPH). 
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DNA Isolation and RFLP Typing 
High-molecular-weight DNA from lymphoblastoid 
cell lines was isolated manually as previously de- 
scribed (Schumm et al., 1987) or automatically by a 
DNA extractor (Model 340A, Applied Biosystems, 
Inc.). The computer program for the DNA extractor 
was modified slightly for the following conditions. 
Isolated nuclei from 30-50 million lymphoblastoid 
cells were injected into each vessel containing 2.9 ml 
of 1X lysis buffer (Applied Biosystems, Inc.) and 25 
units of proteinase K. Samples were digested for 2 h at 
55°C with the vessels mixing at a 140” angle. The 
samples were extracted twice with 4.5 ml of 
phenol:chloroform, followed by a single extraction 
with chloroform (2.7 ml). Sodium acetate (3 M) was 
delivered at 0.33 ml per vessel, followed by 3.1 ml of 
isopropanol. The precipitated DNA was collected on 
Precipitette filters (Applied Biosystems, Inc.), washed 
twice with 70% ethanol, and resuspended in 10 mM 
Tris-hydrochloride (pH 7.5) and 1 mM EDTA to 
a concentration of 250 pg/ml. All reagents for the 
DNA extractor were purchased from Applied Biosys- 
terns, Inc. 
Methods for restriction endonuclease digestion, 
electrophoresis, Southern blotting, hybridization with 
labeled DNA probes, and isolation and characteriza- 
tion of the two RFLP probes, CRI-L581 and 
CRI-L946, are described by Donis-Keller et al. (1987). 
The nerve growth factor receptor probe, pE51, detects 
RFLPs with both Hi&I and XmnI (Breakefield et al, 
1986); however, we have genotyped only the HincII 
RFLP on a subset of 40 of the 45 NFl families. 
Linkage Analysis 
To perform two-point linkage analysis between the 
NFl locus and the linked markers, we derived, by 
hand, an expression for the log likelihood function (as 
a function of the sex average recombination fraction) 
in each NFl family, and then evaluated this expres- 
sion (by computer) for each multiple of 0.01 up to 0.5. 
Complete penetrance at the NFl locus was assumed. 
Multipoint linkage analysis was performed using 
the program CRI-MAP (Barker et al., 1987b; Donis- 
Keller et al., 1987). This program allows rapid maxi- 
mum likelihood estimation of map distances for many 
loci simultaneously, but requires the families ana- 
lyzed to be of “CEPH structure”: i.e., having two par- 
ents, four grandparents (of which some or all may be 
missing), and one or more children. To use this pro- 
gram on the NFl families they were split, where nec- 
essary, into “CEPH structure” subfamilies; this split- 
ting results in loss of information in some families, 
but does not bias the recombination fraction esti- 
mates. The data set used for multipoint linkage analy- 
sis then consisted of the 21 CEPH families on which 
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linkage data for the markers had previously been 
compiled (Donis-Keller et al., 1987), together with the 
data on the (split) NFl families. The multipoint map 
was constructed by sequential addition of loci, using a 
procedure previously described (Barker et al., 1987b; 
Donis-Keller et al., 1987). 
RESULTS 
DNA Probes 
We have two DNA probes, CRI-L581 and 
CRI-L946, that were previously mapped to human 
chromosome 17 by two methods (Donis-Keller et al., 
1987). First, CRI-L581 was assigned to chromosome 
17 by hybridization to panels of somatic cell hybrids. 
Second, both probes were linked to two previously 
localized probes: the chromosome 17 alpha-satellite 
probe, p17H8, which detects the locus D17Zl (Willard 
et al., 1986), and the nerve growth factor receptor 
probe, pE51 (Breakefield et aZ., 1986). CRI-L581 and 
CRI-L946 map near the centromere, with 0% recom- 
bination between p17H8 and CRI-L581, and a 3 CM 
sex-averaged distance between the (p17H8-CRI- 
L581) cluster and CRI-L946 (Donis-Keller et al., 
1987). These three probes, whose unique order could 
not be determined, mapped 17 CM from the nerve 
growth factor receptor locus at 17q12 + 17q22 
(Donis-Keller et aZ., 1987). The previously reported 
linkages between D17Zl and NFl (Barker et al., 
1987a) and between nerve growth factor receptor and 
NFl (Seizinger et al., 1987) indicate that CRI-L581 
FIG. 1. Inheritance of the RFLP detected by CRI-L581. RFLP 
probe CRI-L581 displays three alleles on Southern hybridization to 
DNA digested with TaqI from the CEPH reference family 1341. 
The alleles correspond to fragments of 8.7,7.5, and 7.0 kb, respec- 
tively. The outermost lanes are DNA fragment size markers. 




FIG. 2. Inheritance of the RFLP detected by CRI-L946. RFLP 
probe CRI-L946 displays three alleles on Southern hybridization to 
DNA digested with MspI from the CEPH reference family 1341. 
The alleles correspond to fragments of 8.3,6.3, and 5.2 kb, respec- 
tively. The outermost lanes are DNA fragment size markers. 
and CRI-L946 should also be linked to the NFl locus 
on chromosome 17. 
CRI-L581 has a heterozygosity of 0.55 and detects a 
three-allele restriction fragment length polymor- 
phism (RFLP) with the restriction enzyme TuqI as 
shown in Fig. 1 (Donis-Keller et aZ., 1987). CRI-L946 
has a heterozygosity of 0.43 and detects a three-allele 
RFLP with the enzyme MspI as shown in Fig. 2 
(Donis-Keller et al., 1987). 
Linkage Andy&s 
Genotyping 45 NFl-affected families, comprising 
165 meioses, resulted in 34 families informative for at 
least one of the three probes. Twenty-one families 
were informative for CRI-L581, 23 families for 
CRI-L946, and 10 for pE51. Only 3 NFl families were 
informative for all three markers. The results of the 
linkage analysis are presented in Table 1. One obli- 
gate crossover in 56 meioses occurred between 
CRI-L946 and NFl in family BAY40 (Table 2). Five 
obligate crossovers in 59 meioses occurred between 
CRI-L581 and NFl (Table 2). All individuals with a 
recombination event between NFl and either 
CRI-L581 or CRI-L946 are affected with neurofibro- 
matosis with the exception of the recombinant BAY- 
43-02 (Table 2). 
All families showing recombination events with the 
disease were examined for possible nonpaternity 
and/or sample mixup with either one of two probes 
that detect highly polymorphic DNA sequences: The 
3’HVR probe (heterozygosity = 0.93) associated with 
the HBAl gene on chromosome 16 (Jarman et al., 
1986) or the CRI-L1065 probe (heterozygosity = 0.74) 
on chromosome 6 (Donis-Keller et aZ., 1987; Kazazian 
et al., 1986). The possibility of sample mixup between 
parents or among siblings was examined by probing 
the recombinant families with pDP105, a Y-chromo- 
some-specific probe (Disteche et al., 1986). These 
analyses indicated no sample mixups or nonpaterni- 
ties had occurred in the six recombinant families. Fur- 
thermore, the medical records of all recombinant fam- 
ilies were reexamined and in one family, BAY40, the 
diagnoses of the siblings were verified by repeat physi- 
cal examination at the Baylor Neurofibromatosis 
Program Clinic by V.M.R. 
Pairwise LOD scores for the three DNA markers 
were calculated from the genotypic data on NFl fami- 
lies combined with the previously compiled genotypic 
data on 21 CEPH families (Donis-Keller et al., 1987). 
For the markers CRI-L581 and CRI-L946 the maxi- 
mum LOD score was 32.60 (0 = 0.03), and for markers 
CRI-L581 and pE51 the maximum LOD score was 
10.51 (0 = 0.08). The maximum LOD score of 2.38 (0 
= 0.18) was obtained for CRI-L946 and pE51. 
We have published a multipoint linkage map of 
chromosome 17 with genotypic data on 21 CEPH fam- 
ilies for the following chromosome 17 probes: myosin 
(MYHZ), the centromeric alpha-satellite probe 
p17H8, CRI-L581, CRI-L946, and the nerve growth 
factor receptor probe pE51 (Donis-Keller et al., 1987). 
TABLE 1 
Pairwise LOD Scores for NFl and Chromosome 17 Markers 
LOD score at 0 of 
Marker 0.0 0.1 0.2 0.3 0.4 i 8 CI” 
CRI-L946 -a2 7.14 5.00 2.83 1.01 8.37 0.02 0.0001-0.09 
CRI-L581 
4.: 
5.41 4.42 2.81 1.19 5.43 0.09 0.03-0.20 
pE51 3.62 2.43 1.30 0.41 4.80 0.00 0.0-0.09 
Note. ẑ  = maximum LOD score; 8 = recombination fraction at L 
a One LOD unit confidence interval. 
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TABLE 2 
NFl Families with Recombination Events 
Family 
Recombinant 







03 or 04 
03 or 04 




- R - - - I 
- R - R - 
- R I - I R 
R - - - - - 
- R - - - - 
R - - - - - 
Note. R, recombination event; I, informative, no recombination; -, not informative. 
When multipoint analysis was performed on the of these families yielded positive LOD scores (at B 
combined data set of CEPH families and NFl fami- = 0). Only one recombinant family, BAY25 (Table 2), 
lies, the order of the four loci, Dl7Z1, CRI-L581, has a documented sporadic mutation. Although far 
CRI-L946, and NFl, could not be uniquely deter- from conclusive, these data suggest that in sporadic 
mined. However, the cluster of these four loci mapped cases of NFl at least some of the presumably new 
with greater than 1OO:l odds between myosin (17~13) mutations are probably occurring at the chromosome 
and nerve growth factor receptor (17ql2 + q22). 17 NFl locus. 
DISCUSSION 
To examine the possibility of genetic heterogeneity 
in von Recklinghausen neurofibromatosis we have 
genotyped 45 NFl families with three DNA probes on 
chromosome 17: pE51, CRI-L581, and CRI-L946. The 
results of our linkage analysis show that of 34 families 
informative for at least one of the probes, 28 families 
showed no recombinants between the marker and 
NFl. The maximum LOD scores between NFl and 
each of these markers are significant for linkage 
(Table 1). Although additional NFl loci cannot be 
ruled out, these data provide support for the genetic 
homogeneity of NFl, and for a primary NFl locus 
linked to the chromosome 17 centromeric region. 
Combining the genotypic data collected on the NFl 
families with those previously compiled on the CEPH 
families (see Materials and Methods) provided a suf- 
ficiently large data set for detection of significant dif- 
ferences in female and male recombination frequen- 
cies between some pairs of probes. The sex-specific 
LOD between CRI-L946 and CRI-L581 was 33.90, 
with ~9 for females at 0.06 and B for males at 0.00 (x2 
= 5.98). The sex-specific LOD between CRI-L581 and 
pE51 was 13.13, with 0 for females at 0.39 compared to 
0 = 0.02 for males (X2 = 12.09). Sex-specific differ- 
ences in recombination frequencies have previously 
been reported for the chromosome 17 centromeric re- 
gion (Barker et cd., 1987). 
Six NFl families had one family member with an 
obligate crossover between NFl and one of the DNA 
markers (Table 2). In two of these families there is 
evidence that a crossover has occurred near the chro- 
mosome 17 NFl locus. In family BAY25 there is a 
crossover between CRI-L946 and CRI-L581 (Table 2), 
and a crossover in family BAY28 between pE51 and 
CRI-L581 (Table 2). These data suggest that families 
BAY25 and BAY28 are not cases of genetic heteroge- 
neity. For the remaining four recombinant families 
(Table 2) we have no such evidence; more data are 
needed to determine whether or not these families are 
examples of genetic heterogeneity. We conclude, as 
have others (Barker et aZ., 1987; Seizinger et al., 1987), 
that if there is another locus for NFl besides the one 
identified on chromosome 17, then it accounts for 
only a small percentage of cases. 
Since very few of the NFl recombinant individuals 
are informative for other pairs of loci (Table 2), mul- 
tipoint linkage analysis cannot as yet determine 
whether CRI-L946 and CRI-L581 flank the NFl 
locus. However, preliminary examination of the two- 
point data in Table 2 suggests two possible orders: 
CRI-L946, NFl, CRI-L581 or NFl, CRI-L946, 
CRI-L581. The order of markers in the NFl region 
will become clearer as we isolate and map additional 
probes on the recombinant families. 
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